HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggable Proteome (R03 Clinical Trial Not Allowed)

This is a grant opportunity (R03 Clinical Trial Not Allowed) under the HEAL Initiative for early-stage discovery of new pain targets within the understudied druggable proteome. The funding opportunity is PAR-25-154 and includes multiple CFDA numbers.